Global Irritable Bowel Syndrome Treatment Market is estimated to be valued at US$ 4.04 Bn in 2025 and is expected to reach US$ 7.43 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
US$ 4.04 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
9.10%
2032 Value Projection:
US$ 7.43 Bn
Figure. Irritable Bowel Syndrome Treatment Market Share (%), By Region 2025
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that affects the large intestine. IBS causes abdominal cramping, bloating, gas, and diarrhea and/or constipation. As per National Library of Medicine estimates, in June 2024, IBS affects around 11% of people worldwide. The exact causes of IBS are unknown, but it is believed to be due to changes in the way the gastrointestinal tract handles stress and regulates normal function and sensations. The global irritable bowel syndrome treatment market has been witnessing steady growth over the past few years owing to the increasing prevalence of IBS and growing demand for effective treatment options.
Market Dynamics:
The global irritable bowel syndrome treatment market is driven by the rising geriatric population, as seniors are more prone to develop IBS. According to the United Nations, the number of people aged 60 or above will increase from 962 million globally in 2017 to 2.1 billion in 2050. Moreover, growing awareness and better diagnosis of IBS are also supporting the growth of this market. However, the lack of approved drugs for IBS, high development costs of new therapies, and side effects associated with existing drugs are some of the key factors are hampering the market growth. The development of novel drug formulations and non-drug treatment alternatives can present lucrative opportunities in the market.
Key Features of the Study:
This report provides in-depth analysis of the global irritable bowel syndrome treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global irritable bowel syndrome treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Ironwood Pharmaceuticals, Inc., AbbVie Inc., Astellas Pharma, Inc., Takeda Pharmaceutical Company Limited, AstraZeneca Plc., Sebela Pharmaceuticals, Inc., Bausch Health Companies Inc., Theriva Biologics, Inc., Ardelyx, Inc., Salix Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Inc., GSK plc, and Johnson & Johnson Services, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global irritable bowel syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Market Segmentation
By Type Insights (Revenue, USD Bn, 2020 - 2032)
Irritable Bowel Syndrome with Constipation (IBS-C)
Irritable Bowel Syndrome with Diarrhea (IBS-D)
Mixed Irritable Bowel Syndrome (IBS-M)
By Indication Insights (Revenue, USD Bn, 2020 - 2032)
Abdominal Pain
Bloating
Constipation and Diarrhea
Altered Bowel Habits
Others
By Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
Antispasmodics
Laxatives
Antidiarrheal Medications
5-HT3 Receptor Antagonists
Guanylate Cyclase-C Agonists
Anticholinergic
Probiotics
Antidepressants
Antibiotics
Dietary Supplements
Others
By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
Oral
Rectal
Parenteral
By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional Insights (Revenue, USD Bn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Ironwood Pharmaceuticals, Inc.
AbbVie Inc.
Astellas Pharma, Inc.
Takeda Pharmaceutical Company Limited
AstraZeneca Plc.
Sebela Pharmaceuticals, Inc.
Bausch Health Companies Inc.
Theriva Biologics, Inc.
Ardelyx, Inc.
Salix Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals, Inc.
GSK plc
Johnson & Johnson Services, Inc.
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Irritable Bowel Syndrome Treatment Market, By Type
Global Irritable Bowel Syndrome Treatment Market, By Indication
Global Irritable Bowel Syndrome Treatment Market, By Drug Class
Global Irritable Bowel Syndrome Treatment Market, By Route of Administration
Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel
Global Irritable Bowel Syndrome Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Irritable Bowel Syndrome Treatment Market, By Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Irritable Bowel Syndrome with Constipation (IBS-C)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Irritable Bowel Syndrome with Diarrhea (IBS-D)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Mixed Irritable Bowel Syndrome (IBS-M)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Irritable Bowel Syndrome Treatment Market, By Indication, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Abdominal Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bloating
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Constipation and Diarrhea
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Altered Bowel Habits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Irritable Bowel Syndrome Treatment Market, By Drug Class, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Antispasmodics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laxatives
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antidiarrheal Medications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5-HT3 Receptor Antagonists
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Guanylate Cyclase-C Agonists
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anticholinergic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Probiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antidepressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dietary Supplements
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Irritable Bowel Syndrome Treatment Market, By Route of Administration, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rectal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Irritable Bowel Syndrome Treatment Market, By Region, 2020 - 2032, Value (USD Bn)